Control of lymphocyte homeostasis by iCD8a cells and osteopontin
iCD8a 细胞和骨桥蛋白对淋巴细胞稳态的控制
基本信息
- 批准号:9381773
- 负责人:
- 金额:$ 35.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-05 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAlpha CellAntibodiesAreaBiologicalBiologyCD8-Positive T-LymphocytesCD8B1 geneCellsCitrobacter rodentiumDataDevelopmentDiseaseDisease modelEnhancersEnvironmentEpithelialFoundationsGene Expression ProfileGrantHealthHomeostasisHumanImmuneImmune responseImmunodeficient MouseImmunologicsInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInflammatory disease of the intestineInterleukin-12Intestinal DiseasesIntestinesKnowledgeLigandsLymphocyteLymphocyte BiologyLymphocyte SubsetLymphoidLymphoid CellMaintenanceModelingMouse StrainsMucosal Immune ResponsesMusOsteogenesisPathogenicityPhenotypePopulationPreventiveProcessProductionPublicationsReceptors, Antigen, B-CellResearch ProposalsRoleSourceStimulusSymbiosisT-LymphocyteTNFRSF5 geneTherapeuticTissuesWild Type Mousechemokinecytokineintestinal epitheliumintraepithelialmicroorganismnovelosteopontinprophylactictissue regeneration
项目摘要
SUMMARY
In this application we propose to investigate the biological features of innate CD8 cells (or iCD8 cells), a
novel lymphoid population present in the intestinal epithelium discovered by our group. A hallmark of this
population is the expression of CD8, lack of T and B cell receptors, and the production of
cytokines/chemokines that indicate an innate immune phenotype. iCD8 cells are a main source of
osteoponin in the intestinal epithelium, a cytokine known for its role in tissue remodeling but also for its
capacity to stimulate Th1 and Th17 immune responses. Interestingly, using a strain of mice lacking iCD8
cells (E8I mice; E8I is an essential enhancer for CD8 expression in IEL) we found that the levels of
-/-
osteopontin in the intestinal epithelium are decreased in comparison to wild type mice, and that E8I-/- mice
have a deficiency in NKp46+NK1.1+ IEL. These and other preliminary results have led to the hypothesis that
iCD8 cells, through production of factors such as osteopontin, promote the survival and
maintenance of IEL. In order to pursue this hypothesis, we propose the following complementary, yet
independent aims: Aim1. To determine the contribution of iCD8 cells and osteopontin to IEL
maintenance and survival. In this aim we will determine: a) the impact of iCD8 cells and osteopontin in
the survival and proliferation of different IEL subsets; b) the impact of iCD8 cells and osteopontin in the
immune environment of the intestines; and c) the role of osteopontin ligands in IEL homeostasis. Aim 2. To
define the role of iCD8 cells and osteopontin during intestinal inflammation. In this section we will
determine the role of iCD8 cells and osteopontin in three different disease models: a) intestinal
inflammation by anti-CD40 antibody treatment, b) Citrobacter rodentium infection, and c) inflammation
caused by adoptive transfer of effector T cells into immunodeficient mice. Aim 3. To determine the
mechanisms controlling IEL homeostasis by iCD8 cells. Our previous publication indicates that IL-12
provides stimulus for activation of iCD8 cells. In this section we will determine a) the impact of IL-12 in
activation of iCD8 cells, with implications on OPN secretion and IEL survival, and b) we will determine the
gene expression signature of IEL responding to iCD8 cell/OPN stimulation.
总结
在本申请中,我们提出研究先天性CD 8+细胞(或iCD 8+细胞)的生物学特征,
本研究组发现了存在于肠上皮中的新淋巴样细胞群。这其中的一个标志是
群体的主要特征是表达CD 8受体,缺乏T和B细胞受体,以及产生
细胞因子/趋化因子,其指示先天免疫表型。iCD 8巨噬细胞是
肠上皮中的骨桥蛋白是一种细胞因子,以其在组织重塑中的作用而闻名,
刺激Th 1和Th 17免疫应答的能力。有趣的是,使用缺乏iCD 8的小鼠品系,
细胞(E8 I小鼠; E8 I是IEL中CD 8受体表达的重要增强剂),我们发现,
-/-
与野生型小鼠相比,肠上皮中的骨桥蛋白减少,并且E8 I-/-小鼠
NKp 46 +NK1.1+ IEL缺乏。这些和其他初步结果导致了这样的假设,
iCD 8 β细胞通过产生骨桥蛋白等因子,促进存活,
IEL的维护为了实现这一假设,我们提出了以下补充,但
独立目标:Aim 1.确定iCD 8 β细胞和骨桥蛋白对IEL的贡献
维持和生存。在这个目标中,我们将确定:a)iCD 8 β细胞和骨桥蛋白对骨形成的影响。
不同IEL亚群的存活和增殖; B)iCD 8+细胞和骨桥蛋白在IEL亚群中的影响。
肠的免疫环境;和c)骨桥蛋白配体在IEL稳态中的作用。目标2.到
明确iCD 8巨噬细胞和骨桥蛋白在肠道炎症中的作用。本节我们将
确定iCD 8 β细胞和骨桥蛋白在三种不同疾病模型中的作用:
通过抗CD 40抗体治疗的炎症,B)啮齿类柠檬酸杆菌感染,和c)炎症
由效应T细胞过继转移到免疫缺陷小鼠引起。目标3。确定
通过iCD 8 β细胞控制IEL稳态的机制。我们先前的出版物表明IL-12
为iCD 8 β细胞的活化提供刺激。在本节中,我们将确定a)IL-12在
iCD 8 β细胞的活化,对OPN分泌和IEL存活的影响,和B)我们将确定
IEL对iCD 8+细胞/OPN刺激的响应的基因表达特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Danyvid Olivares-Villagomez其他文献
Danyvid Olivares-Villagomez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Danyvid Olivares-Villagomez', 18)}}的其他基金
Control of lymphocyte homeostasis by iCD8a cells and osteopontin
iCD8a 细胞和骨桥蛋白对淋巴细胞稳态的控制
- 批准号:
10178005 - 财政年份:2017
- 资助金额:
$ 35.55万 - 项目类别:
Characterization of CD8a cells as a novel immune population of the intestines
CD8a 细胞作为肠道新型免疫群体的表征
- 批准号:
9252837 - 财政年份:2014
- 资助金额:
$ 35.55万 - 项目类别:
相似海外基金
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
- 批准号:
10678248 - 财政年份:2023
- 资助金额:
$ 35.55万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 35.55万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10427574 - 财政年份:2022
- 资助金额:
$ 35.55万 - 项目类别:
Regulation of alpha-cell glucagon secretion by mitochondrial anaplerosis-cataplerosis
线粒体回补-回补对α细胞胰高血糖素分泌的调节
- 批准号:
10607392 - 财政年份:2022
- 资助金额:
$ 35.55万 - 项目类别:
Arginine regulation of alpha cell proliferation and function
精氨酸调节α细胞增殖和功能
- 批准号:
10609909 - 财政年份:2022
- 资助金额:
$ 35.55万 - 项目类别:
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
靶向 α 细胞 GPCR 刺激胰高血糖素并对抗低血糖
- 批准号:
10675646 - 财政年份:2022
- 资助金额:
$ 35.55万 - 项目类别:
Elucidating alpha cell defects in human type 1 diabetes using precision cut pancreas slice-on-a-chip coupled with high spatio-temporal microscopy
使用精密切割的胰腺切片结合高时空显微镜阐明人类 1 型糖尿病的 α 细胞缺陷
- 批准号:
457552 - 财政年份:2021
- 资助金额:
$ 35.55万 - 项目类别:
Studentship Programs
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
定义 2 型糖尿病治疗的 α 细胞胰高血糖素原加工过程
- 批准号:
10331361 - 财政年份:2020
- 资助金额:
$ 35.55万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 35.55万 - 项目类别:
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
定义 2 型糖尿病的 α 细胞 PC1/3 表达调控
- 批准号:
10376866 - 财政年份:2020
- 资助金额:
$ 35.55万 - 项目类别: